Chiropractic Instead of Opioids: Million-Patient Study
Dynamic Chiropractic Staff
Could 1 million patients help end the opioid crisis, position chiropractic as a front-line pain-relief service and in so doing, effectively change the face of health care? The Council on Chiropractic Guidelines and Practice Parameters (CCGPP) / Clinical Compass certainly hopes so. With one study already completed and pending publication, a second, significantly larger study is about to get underway that, like the first, will investigate how chiropractic care impacts opioid and medication use.
Dr. James Whedon, director of health services research at Southern California University of Health Sciences and recent appointee as co-chair of the policy committee of the Integrative Complementary Traditional Health Practices section of the American Public Health Association, will serve as principal investigator on the second study, as he did on the first. Performance Health is providing significant financial support to the Clinical Compass, with funds earmarked for this second study, which is set to begin by year’s end and should yield reportable data within 18 months.
"This second study will have a massive impact on patients, providers of health services, payers and policy makers," said Jay Greenstein, DC, chairman of the Clinical Compass. "We will not just be moving the needle with this study, we will be changing the game on how healthcare is delivered in our country, and be a major force in reducing opioid addiction."
The first study, conducted last year and involving more than 12,000 LBP patients, found that patients who visited a chiropractor were significantly less likely to fill an opioid prescription and accrued dramatically lower annual charges for opioid prescriptions compared to non-recipients of chiropractic care.
To learn more about the Clinical Compass and access research-based clinical practice guidelines spearheaded by the Compass, visit www.clinicalcompass.org.
The chiropractic profession is under a sophisticated and relentless assault from corporate medicine, so strategically executed that most don’t even recognize it happening. The campaign is powerful, calculated, and well-funded, demonstrated by its covert tactics and the millions being invested to carry it out. Corporate medicine's endgame wants only two things from chiropractic: all our patients and all our money – and it is getting it.
Over the past two decades, more than 18 million spinal surgeries have been performed in the United States, and cervical disc replacements represent a fair share of those. Device recalls due to design flaws can place patients in difficult clinical situations, especially those who are symptomatic and reluctant to undergo revision surgery. This case highlights the role of chiropractors in managing complex postsurgical patients, particularly those with recalled spinal implants.
UnitedHealth Group, parent company of UnitedHealthcare, has announced sweeping changes to its prior-authorization (PA) requirements that will eliminate the requirement for chiropractic care and numerous other healthcare services by the end of 2026. Doctors of chiropractic, other providers and patients have long lamented prior authorization requirements because they can delay needed treatment, limit access and even cause some patients not to pursue care.
